Circulating Adiponectin Is Associated with Renal Function Independent of Age and Serum Lipids in West Africans

Ayo P. Doumatey, Jianlong Zhou, Hung‐Ling Huang, Jokotade Adeleye, Williams Balogun, O.a Fasanmade, Thomas Johnson, J Oli, G Okafor, A.g.b. Amoah, Ba Eghan, Kofi Agyenim‐Boateng, Joseph Acheampong, Clement Adebamowo, Adebowale Adeyemo, Charles N. RotimiInternational Journal of Nephrology 2012 · DOI

TL;DR

This study investigates the link between adiponectin, a hormone produced by fat cells, and kidney function in West African adults without diabetes. They found that higher levels of adiponectin are associated with poorer kidney function, and this relationship holds true even after accounting for age and lipid levels, suggesting adiponectin could be a useful biomarker for kidney health in this population.

What Problem Does This Paper Address?

Kidney disease is a growing concern, particularly in sub-Saharan Africa. While previous research has hinted at a connection between adiponectin and kidney dysfunction, much of this evidence comes from studies on individuals already diagnosed with metabolic diseases like diabetes. There's a significant gap in understanding this relationship within generally healthy populations, especially in underrepresented groups like West Africans. This study aims to fill that gap by examining whether adiponectin levels can predict kidney function in a cohort of nondiabetic West African adults, independent of common confounding factors.

Methods

The researchers employed a cross-sectional study design, analyzing data from 792 nondiabetic West African participants. Key methods included:

  • Anthropometric and Clinical Measurements: Standardized measurements of height, weight, waist circumference, and blood pressure were taken.
  • Biochemical Assays: Fasting serum samples were analyzed for creatinine, HDL-C, LDL-C, and triglycerides using an autoanalyzer. Total serum adiponectin was measured using a commercially available immunoassay kit.
  • Renal Function Estimation: Estimated Glomerular Filtration Rate (eGFR) was calculated using two common methods: the Modification of Diet in Renal Diseases (MDRD) formula and the Cockcroft-Gault (CG) formula. This dual approach was used because no single eGFR equation has been universally validated for African populations.
  • Statistical Analysis:
    • Linear Regression: Used to assess the association between eGFR (as the dependent variable) and adiponectin (as the explanatory variable), adjusting for potential confounders like age, sex, BMI, hypertension, smoking, and serum lipids.
  • Logistic Regression: Employed to determine predictors of moderate chronic kidney disease (defined as eGFR < 60 mL/min/1.73 m²) based on adiponectin levels.

Datasets

The study utilized data from the Africa America Diabetes Mellitus (AADM) study, a project focused on the genetic and environmental determinants of type 2 diabetes and its comorbidities in West Africa. The specific dataset for this paper comprised 792 nondiabetic participants from three centers in Nigeria and two in Ghana. No new benchmarks were introduced; rather, existing validated measurement techniques and statistical models were applied.

Key Insights and Ideas

  • Adiponectin as a potential kidney biomarker: The study strongly suggests that circulating adiponectin levels can serve as a useful indicator of kidney function, even in individuals without overt metabolic diseases.
  • Independence from age and lipids: A crucial finding is that the inverse relationship between adiponectin and eGFR persists even after statistically controlling for age and serum lipid profiles. This is significant because age and lipids are well-established factors influencing kidney health.
  • Methodological considerations for eGFR: The study highlights the differences in CKD prevalence when using MDRD versus CG formulas, with CG identifying a higher proportion of individuals with moderate CKD. This underscores the importance of considering the chosen eGFR estimation method and its potential limitations in specific populations.
  • Adiponectin's role beyond metabolic disease: By focusing on a nondiabetic cohort, the research extends the known association of adiponectin with kidney function beyond the context of diabetes and other overt metabolic disorders.

Key Results

  • Inverse relationship: Adiponectin showed a consistent inverse relationship with eGFR in both univariate and multivariate analyses.
  • Multivariate model performance: The multivariate models, which included adiponectin along with age, sex, BMI, hypertension, smoking, and serum lipids, explained a substantial portion of the variance in GFR: 30% for MDRD-estimated GFR and 55.6% for CG-estimated GFR.
  • Predictor of moderate CKD: Adiponectin was identified as a significant independent predictor of moderate chronic kidney disease (eGFR < 60 mL/min/1.73 m²), regardless of the eGFR estimation method used.
  • CG vs. MDRD: The association between eGFRCG and adiponectin was stronger than that between eGFRMDRD and adiponectin, potentially due to the CG formula's inclusion of anthropometric measurements.

Limitations and Future Work

The authors acknowledge several limitations:

  • Cross-sectional design: This study design does not allow for the determination of causality; it only shows associations. Longitudinal studies are needed to establish a cause-and-effect relationship.
  • eGFR suitability: The MDRD-based eGFR estimation may not be universally suitable for all populations, particularly Africans, and the study did not collect detailed dietary data to control for potential dietary influences.
  • Definition of moderate CKD: The definition of moderate CKD was solely based on eGFR, without incorporating other markers like proteinuria or albuminuria, which could provide a more comprehensive assessment.

Future work suggested includes:

  • Longitudinal studies: To establish causality and track changes in adiponectin and renal function over time.
  • Population-based studies: To further validate these findings across diverse populations.
  • Investigation of adiponectin isomers: Exploring the role of different forms of adiponectin (e.g., high molecular weight adiponectin) in kidney function, as these may have varying effects.
  • Inclusion of other biomarkers: Incorporating additional markers like apolipoprotein A-IV, fibroblast growth factor 23, and natriuretic peptides to develop more discriminatory biomarkers for CKD progression.

Summary updated

Abstract

Adiponectin, a protein secreted by adipose tissue, has been associated with renal dysfunction. However, these observations have not been adequately investigated in large epidemiological studies of healthy individuals in general and in African populations in particular. Hence, we designed this study to evaluate the relationship between adiponectin and renal function in a large group of nondiabetic West Africans. Total adiponectin was measured in 792 participants. MDRD and Cockroft-Gault (CG-) estimated GFR were used as indices of renal function. Linear and logistic regression models were used to determine the relationship between adiponectin and renal function. Adiponectin showed an inverse relationship with eGFR in univariate (Beta(MDRD) = -0.18, Beta(CG) = -0.26) and multivariate (Beta(MDRD) = -0.10, Beta(CG) = -0.09) regression analyses. The multivariate models that included age, sex, BMI, hypertension, smoking, HDL-C, LDL-C, triglycerides, and adiponectin explained 30% and 55.6% of the variance in GFR estimated by MDRD and CG methods, respectively. Adiponectin was also a strong predictor of moderate chronic kidney disease (defined as eGFR < 60 mL/min/1.73 m(2)). We demonstrate that adiponectin is associated with renal function in nondiabetic West Africans. The observed relationship is independent of age and serum lipids. Our findings suggest that adiponectin may have clinical utility as a biomarker of renal function.
BibTeX
@article{doumatey2012circulating,
  author = {Ayo P. Doumatey and Jianlong Zhou and Hung‐Ling Huang and Jokotade Adeleye and Williams Balogun and O.A Fasanmade and Thomas Johnson and J Oli and G Okafor and A.G.B. Amoah and BA Eghan and Kofi Agyenim‐Boateng and Joseph Acheampong and Clement Adebamowo and Adebowale Adeyemo and Charles N. Rotimi},
  title = {{Circulating Adiponectin Is Associated with Renal Function Independent of Age and Serum Lipids in West Africans}},
  journal = {International Journal of Nephrology},
  year = {2012},
  doi = {10.1155/2012/730920},
}
Figure